Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study

[1] Jennette JC(1994)Nomenclature of systemic vasculitides. Proposal of an international consensus conference Arthritis Rheum 37 187-192

[2] Hamour S(2010)Management of ANCA-associated vasculitis: current trends and future prospects Ther Clin Risk Manag 6 253-264

[3] Salama AD(2007)Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis J Am Soc Nephrol 18 2180-2188

[4] Pusey CD(2013)Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear Kidney Int 84 397-402

[5] Jayne DR(2012)Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease Clin J Am Soc Nephrol 7 240-247

[6] Walsh M(2009)Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients Ann Rheum Dis 68 658-663

[7] McGregor JG(2013)Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis Clin J Am Soc Nephrol 8 416-423

[8] Charlier C(2009)Adverse effects of therapy for ANCA-associated vasculitis Best Pract Res Clin Rheumatol 23 391-401

[9] Goupil R(2012)Evaluation of weekly-reduction regimen of glucocorticoids in combination with cyclophosphamide for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis in Japanese patients Rheumatol Int 32 2999-3005

[10] Turnbull J(2015)Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis study group trials Rheumatology (Oxford) 54 471-481

[1] Jennette JC(1994)Nomenclature of systemic vasculitides. Proposal of an international consensus conference Arthritis Rheum 37 187-192

[2] Hamour S(2010)Management of ANCA-associated vasculitis: current trends and future prospects Ther Clin Risk Manag 6 253-264

[3] Salama AD(2007)Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis J Am Soc Nephrol 18 2180-2188

[4] Pusey CD(2013)Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear Kidney Int 84 397-402

[5] Jayne DR(2012)Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease Clin J Am Soc Nephrol 7 240-247

[6] Walsh M(2009)Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients Ann Rheum Dis 68 658-663

[7] McGregor JG(2013)Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis Clin J Am Soc Nephrol 8 416-423

[8] Charlier C(2009)Adverse effects of therapy for ANCA-associated vasculitis Best Pract Res Clin Rheumatol 23 391-401

[9] Goupil R(2012)Evaluation of weekly-reduction regimen of glucocorticoids in combination with cyclophosphamide for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis in Japanese patients Rheumatol Int 32 2999-3005

[10] Turnbull J(2015)Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis study group trials Rheumatology (Oxford) 54 471-481